newsfilter
← Latest News
GlobeNewswire·

Liquidia Corporation Reports Third Quarter 2026 Financial Results

YUTREPIA® (treprostinil) inhalation powder net product sales of $222.7 million in the third quarter of 2026, up 31% from the second quarter of 2026October 2026 total patient shipments reached their highest monthly level